FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017378797> ?p ?o ?g. }

• W2017378797 endingPage "1127" @default.
• W2017378797 startingPage "1117" @default.
• W2017378797 abstract "The aim of the study was to investigate whether the antidepressant trazodone (TRZ), a serotonin-2 receptor antagonist/reuptake inhibitor, modifies γ-amino-butyric acid (GABA) extracellular levels in the cerebral cortex, by acting on 5-HT2A receptors, and through this mechanism increases 5-HT levels. For this purpose the effect of TRZ on the release of GABA was studied in adult male rats in synaptosomes, cortical slices, and “in vivo” by microdialysis. In cortical slices, the release of both GABA and 5-HT was determined. GABA and 5-HT were identified and their levels quantified by HPLC. The inhibition of 5-HT uptake by TRZ was also measured. In synaptosomes, TRZ antagonized dose-dependently, at concentrations from 10−10 to 10−6 M, the increase in GABA release induced by (±)DOI, a 5-HT2A/2C agonist, and the α receptor agonist phenylephrine, both 10−6 M. The pIC50 values were 8.31±0.24, and 5.99±0.52, respectively. In the same preparation, [3H]5-HT accumulation was inhibited by citalopram and TRZ with pIC50 of 7.8±0.44 and 5.9±0.09, respectively, a finding confirming the weak activity of TRZ in comparison with a SSRI. In cortical slices, TRZ exerted a biphasic effect on GABA release. At concentrations from 10−10 to 10−7 M it inhibited and from 10−6 to 10−4 M increased GABA release. 5-HT release was enhanced by TRZ throughout the entire range of concentrations tested. However, the increase was delayed after low and rapid after high concentrations. AMI-193, a 5-HT2A antagonist (10−10 to 10−5 M), reduced GABA release in a dose–response manner, while it induced an increase of 5-HT outflow. On the contrary, (±)DOI (10−10 to 10−5 M) increased GABA release and inhibited 5-HT levels. Perfusion with the GABAA receptor antagonist bicuculline was also followed by an increase in 5-HT release. In microdialysis experiments, TRZ 1.25 mg kg−1 s.c. brought about a decrease in GABA extracellular levels, while an increase was found after the dose of 2.5 mg kg−1. These findings demonstrate that TRZ, at concentrations which do not inhibit 5-HT uptake, reduces the cortical GABAergic tone by decreasing GABA extracellular levels, through the blockade of 5-HT2A receptors. The attenuation of GABAergic tone is responsible for an increase in 5-HT levels. A further increase also results from 5-HT uptake inhibition caused by higher doses of TRZ. The ensuing high 5-HT levels enhance GABA release, which in turn inhibits 5-HT release." @default.
• W2017378797 created "2016-06-24" @default.
• W2017378797 creator A5037748439 @default.
• W2017378797 creator A5052439688 @default.
• W2017378797 creator A5053047266 @default.
• W2017378797 creator A5086746725 @default.
• W2017378797 creator A5091545540 @default.
• W2017378797 date "2004-11-01" @default.
• W2017378797 modified "2023-10-18" @default.
• W2017378797 title "A cortical GABA–5HT interaction in the mechanism of action of the antidepressant trazodone" @default.
• W2017378797 cites W1907932603 @default.
• W2017378797 cites W1986938874 @default.
• W2017378797 cites W1987191386 @default.
• W2017378797 cites W1994702289 @default.
• W2017378797 cites W1996274550 @default.
• W2017378797 cites W2000859735 @default.
• W2017378797 cites W2004172377 @default.
• W2017378797 cites W2006285647 @default.
• W2017378797 cites W2009823135 @default.
• W2017378797 cites W2023234275 @default.
• W2017378797 cites W2026246966 @default.
• W2017378797 cites W2030101484 @default.
• W2017378797 cites W2030828774 @default.
• W2017378797 cites W2040118919 @default.
• W2017378797 cites W2042556300 @default.
• W2017378797 cites W2042717783 @default.
• W2017378797 cites W2064756514 @default.
• W2017378797 cites W2076112136 @default.
• W2017378797 cites W2080204649 @default.
• W2017378797 cites W2086913299 @default.
• W2017378797 cites W2091171404 @default.
• W2017378797 cites W2124642613 @default.
• W2017378797 cites W2135763988 @default.
• W2017378797 cites W2153973366 @default.
• W2017378797 cites W326814059 @default.
• W2017378797 cites W4293247451 @default.
• W2017378797 doi "https://doi.org/10.1016/j.pnpbp.2004.05.046" @default.
• W2017378797 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15610924" @default.
• W2017378797 hasPublicationYear "2004" @default.
• W2017378797 type Work @default.
• W2017378797 sameAs 2017378797 @default.
• W2017378797 citedByCount "37" @default.
• W2017378797 countsByYear W20173787972012 @default.
• W2017378797 countsByYear W20173787972013 @default.
• W2017378797 countsByYear W20173787972014 @default.
• W2017378797 countsByYear W20173787972015 @default.
• W2017378797 countsByYear W20173787972016 @default.
• W2017378797 countsByYear W20173787972017 @default.
• W2017378797 countsByYear W20173787972018 @default.
• W2017378797 countsByYear W20173787972019 @default.
• W2017378797 countsByYear W20173787972020 @default.
• W2017378797 countsByYear W20173787972021 @default.
• W2017378797 countsByYear W20173787972023 @default.
• W2017378797 crossrefType "journal-article" @default.
• W2017378797 hasAuthorship W2017378797A5037748439 @default.
• W2017378797 hasAuthorship W2017378797A5052439688 @default.
• W2017378797 hasAuthorship W2017378797A5053047266 @default.
• W2017378797 hasAuthorship W2017378797A5086746725 @default.
• W2017378797 hasAuthorship W2017378797A5091545540 @default.
• W2017378797 hasBestOaLocation W20173787972 @default.
• W2017378797 hasConcept C126322002 @default.
• W2017378797 hasConcept C134018914 @default.
• W2017378797 hasConcept C170493617 @default.
• W2017378797 hasConcept C185592680 @default.
• W2017378797 hasConcept C202751555 @default.
• W2017378797 hasConcept C2775864247 @default.
• W2017378797 hasConcept C2776120743 @default.
• W2017378797 hasConcept C2776219046 @default.
• W2017378797 hasConcept C2777490545 @default.
• W2017378797 hasConcept C2777952589 @default.
• W2017378797 hasConcept C2778938600 @default.
• W2017378797 hasConcept C2779177272 @default.
• W2017378797 hasConcept C2780980600 @default.
• W2017378797 hasConcept C2781161787 @default.
• W2017378797 hasConcept C28406088 @default.
• W2017378797 hasConcept C50156730 @default.
• W2017378797 hasConcept C53910766 @default.
• W2017378797 hasConcept C55493867 @default.
• W2017378797 hasConcept C71924100 @default.
• W2017378797 hasConcept C84393581 @default.
• W2017378797 hasConcept C86803240 @default.
• W2017378797 hasConcept C98274493 @default.
• W2017378797 hasConcept C99631742 @default.
• W2017378797 hasConceptScore W2017378797C126322002 @default.
• W2017378797 hasConceptScore W2017378797C134018914 @default.
• W2017378797 hasConceptScore W2017378797C170493617 @default.
• W2017378797 hasConceptScore W2017378797C185592680 @default.
• W2017378797 hasConceptScore W2017378797C202751555 @default.
• W2017378797 hasConceptScore W2017378797C2775864247 @default.
• W2017378797 hasConceptScore W2017378797C2776120743 @default.
• W2017378797 hasConceptScore W2017378797C2776219046 @default.
• W2017378797 hasConceptScore W2017378797C2777490545 @default.
• W2017378797 hasConceptScore W2017378797C2777952589 @default.
• W2017378797 hasConceptScore W2017378797C2778938600 @default.
• W2017378797 hasConceptScore W2017378797C2779177272 @default.
• W2017378797 hasConceptScore W2017378797C2780980600 @default.
• W2017378797 hasConceptScore W2017378797C2781161787 @default.
• W2017378797 hasConceptScore W2017378797C28406088 @default.

• next